35 results
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;
(f)the future value … payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments;
(f) the future value of the Shares underlying
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
/retirement benefits, will be provided by or paid for by the Company. Notwithstanding the foregoing, during the Employment Term, the Company will pay
8-K
EX-99.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
as Athira’s Chief Medical Officer and congratulate him on his retirement. In addition to his five years with Athira, Hans has more than 30 years
8-K
ATHA
Athira Pharma Inc
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
employment with the Company on a transitional, at-will basis from the Transition Date until her retirement date, which, at the latest, will occur on June 16 … Business Officer and the transition and retirement of Ms. Mileson is attached as Exhibit 99.1 and is incorporated herein by reference.
Item 5.07
8-K
EX-99.1
tr532 3249j
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.2
l02qef 9i8qi
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.3
jfc9zw9dkpixsvoskro
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
mxi2xw0fxnxof0n
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
S-3
EX-4.3
5lmgd1dwf3zz7wea3
15 Nov 21
Shelf registration
4:06pm
8-K
EX-10.1
qh8hi h3g
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
10-K
l743idrb3g6gmkovxnlj
25 Mar 21
Annual report
12:00am
424B4
a6cwbpv jd
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
bxel34
6 Jan 21
Draft registration statement
12:00am
424B4
h81c4vt7hc7k
18 Sep 20
Prospectus supplement with pricing info
4:05pm